ArticleCancers2022

Evaluation of Blood Soluble CD26 as a Complementary Biomarker for Colorectal Cancer Screening Programs.

Loretta De Chiara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.